MOR-8457

N/A

Report date: 2024/09/09 14:26:04

Base Information

Drug NameMOR-8457
Drug Alias NameMOR-8457
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionPlatelet-derived growth factor subunit B inhibitors
TargetsPlatelet-derived growth factor subunit B
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScholar Rock LlcPfizer Japan IncRoche Diagnostics Gmbh +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesScholar Rock LlcMorphosys AgRoche Diagnostics Gmbh +[4] 
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A